Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 4, 2025
Background:
Tubulin
alpha
1b
(TUBA1B)
is
a
key
microtubule
protein
essential
for
maintaining
cellular
structure
and
function.
This
contributes
significantly
to
cytoskeletal
formation
implicated
in
various
diseases.
Despite
its
fundamental
roles,
TUBA1B’s
impact
on
tumor
prognosis
the
immune
microenvironment
across
cancer
types
remains
inadequately
understood.
Methods
To
elucidate
role
response,
we
conducted
comprehensive
analysis,
integrating
data
from
established
databases
such
as
The
Cancer
Genome
Atlas,
Genotype
Tissue
Expression,
Cell
Lineage
Encyclopedia,
Human
Protein
Kaplan-Meier
Plotter,
cBioPortal,
TIMER,
ImmuCellAI,
along
with
large-scale
clinical
study
immunotherapy
cohort.
We
also
vitro
functional
assays
assess
cells,
allowing
detailed
examination
of
relationship
modulation.
Results:
Our
findings
indicate
that
TUBA1B
expression
dysregulated
multiple
cancers,
correlating
strongly
poor
survival
outcomes
advanced
pathological
stages.
Functional
enrichment
analyses
further
revealed
regulates
cell
cycle
processes,
driving
proliferation,
migration,
invasion.
It
influences
functions
within
both
innate
adaptive
systems,
affecting
immune-related
signaling
pathways.
These
insights
underscore
multifaceted
progression
response.
Conclusion:
highlights
potential
human
oncogene
substantial
roles
tumorigenesis
regulation.
Elevated
levels
are
associated
an
immunosuppressive
microenvironment,
impacting
treatment
outcomes.
Targeting
may
offer
promising
therapeutic
avenues
enhancing
treatment,
offering
new
perspectives
innovative
anti-tumor
strategies
high
impact.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Aug. 19, 2024
Cancer
is
one
of
the
most
concerning
public
health
issues
and
breast
cancer
common
cancers
in
world.
The
immune
cells
within
tumor
microenvironment
regulate
development.
In
this
study,
single
cell
data
sets
were
used
to
identify
marker
gene
for
exhausted
CD8
+
T
(CD8Tex)
cancer.
Machine
learning
methods
cluster
subtypes
establish
prognostic
models
with
bulk
using
evaluate
impacts
CD8Tex.
We
analyzed
overexpressing
survival-associated
genes
identified
CD8Tex
hub
protein-protein-interaction
network.
relevance
T-cells
was
evaluated.
clinical
associations
sequencing
spatial
data.
pan-cancer
expression,
survival,
association
analyzed.
biomarker
CD8Tex-based
subtyping
systems
performed
well
separation
patients
different
survival.
CRTAM,
CLEC2D,
KLRB1
as
demonstrated
have
potential
therapy
impact.
This
study
provides
a
unique
view
critical
therapy.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(1), P. e0314745 - e0314745
Published: Jan. 16, 2025
Cancer
remains
one
of
the
most
significant
public
health
challenges
worldwide.
A
widely
recognized
hallmark
cancer
is
ability
to
sustain
proliferative
signaling,
which
closely
tied
various
cell
cycle
processes.
Centromere
Protein
(CENPA),
a
variant
standard
histone
H3,
crucial
for
selective
chromosome
segregation
during
cycle.
Despite
its
importance,
comprehensive
pan-cancer
bioinformatic
analysis
CENPA
has
not
yet
been
conducted.
Data
on
genomes,
transcriptomes,
and
clinical
information
were
retrieved
from
publicly
accessible
databases.
We
analyzed
CENPA's
genetic
alterations,
mRNA
expression,
functional
enrichment,
association
with
stemness,
mutations,
expression
across
populations
cellular
locations,
link
cycle,
impact
survival,
relationship
immune
microenvironment.
Additionally,
prognostic
model
glioma
patients
was
developed
demonstrate
potential
as
biomarker.
Furthermore,
drugs
targeting
in
cells
identified
predicted
using
drug
sensitivity
correlations
protein-ligand
docking.
exhibited
low
levels
gene
mutation
cancers.
It
found
be
overexpressed
nearly
all
types
TCGA,
relative
normal
controls,
predominantly
located
nucleus
malignant
cells.
showed
strong
particularly
biomarker
G2
phase.
also
emerged
valuable
diagnostic
multiple
types.
In
glioma,
demonstrated
reliable
when
used
alongside
other
factors.
linked
Drugs
such
CD-437,
3-Cl-AHPC,
Trametinib,
BI-2536,
GSK461364
target
serves
cancers,
offering
both
value.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1285 - 1285
Published: Feb. 2, 2025
Targeting
the
tumor
microenvironment
(TME)
is
an
attractive
strategy
for
developing
new
drugs
with
anticancer
activity
against
triple-negative
breast
cancer
(TNBC).
Interleukins
(ILs)
are
key
players
in
TME
cytokine
network
promoting
progression.
Recent
studies
have
highlighted
involvement
of
IL-20
receptor
subunit
alpha
(IL-20RA)
signalling
several
cancers,
including
BC,
which
IL-20RA
highly
expressed,
correlating
poor
prognosis
and
influencing
tumoral
characteristics
such
as
proliferation,
cell
death,
invasiveness,
activity.
Therefore,
elucidating
role
pathway
could
form
basis
therapeutic
strategies.
This
study
aimed
to
identify
selective
bioactive
ligands
able
affect
Virtual
screening
over
310,000
compounds
from
both
DrugBank
ZINC15
databases
identified
four
potential
hit
tested
their
TNBC
vitro
lines.
Notably,
Ritonavir,
a
well-known
Human
Immunodeficiency
Virus
Type
1
(HIV-1)
protease
inhibitor,
significantly
inhibited
proliferation
(about
40%
at
50
µM,
p
<
0.001).
preincubation
counteracted
Ritonavir’s
cytostatic
effect
while
knockdown
restored
Ritonavir-treated
cells.
In
conclusion,
these
findings
demonstrated
that
Ritonavir
reduced
through
modulation,
suggesting
its
repurposing
agent
management.
Hereditas,
Journal Year:
2025,
Volume and Issue:
162(1)
Published: March 19, 2025
Abstract
Background
Genes
that
participate
in
the
absorption,
distribution,
metabolism,
excretion
(ADME)
processes
occupy
a
central
role
pharmacokinetics.
Meanwhile,
variability
clinical
outcomes
and
responses
to
treatment
is
notable
bladder
cancer
(BLCA).
Methods
Our
study
utilized
expansive
datasets
from
TCGA
GEO
explore
prognostic
factors
cancer.
Utilizing
both
univariate
Cox
regression
lasso
techniques,
we
identified
ADME
genes
critical
for
patient
outcomes.
our
study,
model
assessing
risk
was
constructed.
The
evaluation
of
this
model's
predictive
precision
conducted
using
Kaplan–Meier
survival
curves
assessments
based
on
ROC
curves.
Furthermore,
devised
nomogram,
offering
straightforward
visualization
crucial
indicators.
To
potential
mediating
differences
between
high
low
groups,
performed
comprehensive
analyses
including
Gene
Ontology
(GO)
Kyoto
Encyclopedia
Genomes
(KEGG)-based
enrichment
analyses,
immune
infiltration
variations,
somatic
mutation
landscapes,
pharmacological
sensitivity
response
assessment
etc.
Immediately
following
this,
selected
core
PPI
network
explored
as
well
modulation,
pathway
activation.
And
differential
expression
verified
by
immunohistochemistry
qRT-PCR.
Finally
pan-cancer
biomarkers.
Results
efforts
culminated
establishment
validated
17-gene
ADME-centered
prediction
model,
displaying
remarkable
accuracy
BLCA
prognosis.
Through
separate
cox
importance
model’s
score
forecasting
substantiated.
novel
nomogram
incorporating
variables
alongside
introduced.
Comprehensive
studies
established
strong
correlation
several
key
indicators:
patterns
cell
infiltration,
reactions
immunotherapy,
landscape
profiles
drug
sensitivity.
We
screened
gene
CYP2C8,
its
tumor
bioregulation
upregulated
found
it
can
serve
reliable
biomarker
pan-cancer.
Conclusion
formulated
research
stands
formidable
instrument
prognosis,
while
also
providing
insights
into
disease's
progression
mechanisms
guiding
decision-making
strategies.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(16), P. 3886 - 3886
Published: Aug. 16, 2024
Artemisinin
is
a
natural
sesquiterpene
lactone
obtained
from
the
traditional
Chinese
medicinal
herb
Artemisia
annua
L.
(qinghao).
and
its
derivatives
share
an
unusual
endoperoxide
bridge
are
extensively
used
for
malaria
treatment
worldwide.
In
addition
to
antimalarial
activities,
artemisinin
have
been
reported
exhibit
promising
anticancer
effects
in
recent
decades.
this
review,
we
focused
on
research
progress
of
with
potential
activities.
The
pharmacological
effects,
mechanisms,
clinical
trials
cancer
therapy
were
discussed.
This
review
may
facilitate
future
exploration
as
effective
agents.
Cancer Cell International,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Jan. 3, 2025
Tumor
microenvironment
(TME)
plays
a
crucial
role
in
tumor
growth
and
metastasis.
Exploring
biomarkers
that
are
significantly
associated
with
TME
can
help
guide
individualized
treatment
of
patients.
We
analyzed
the
expression
survival
P4HB
pan-cancer
through
TCGA
database,
verified
protein
level
by
HPA
database.
In
addition,
we
used
Metascape
database
to
construct
protein–protein
interaction
networks
single-cell
Sequencing
for
functional
analysis.
An
immune
cell
infiltration
analysis
was
performed
explore
potential
TME.
further
analyze
relationship
between
checkpoint
molecules
blockade
therapy.
Finally,
oncogenic
RCC
cells
validated
using
colony
formation
wound
healing
assays.
RNA
levels
were
extensively
up-regulated
pan-cancer.
However,
high
poor
KIRC.
The
clinical
relevance
analyses
suggested
advanced
TNM
stage.
Moreover,
multivariate
cox
regression
indicated
(HR
=
1.372,
95%
CI
1.047–1.681,
P
0.019)
an
independent
risk
factor
OS
Functional
revealed
is
involved
hypoxia,
system
processes.
Our
study
also
found
correlated
elevated
CD8
+
T
M2
macrophages.
results
assays
showed
knockdown
inhibited
migration.
specific
biomarker
KIRC
prognosis
characteristics.
may
play
influential
ICB